RICHARD KNIPE MD NPI 1336120336

NPI Information

  • NPI: 1336120336
  • Provider Name: RICHARD KNIPE, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • Address: 375 BRIGHTWATERS BLVD NE
    ST PETERSBURG, FL
    ZIP 33704
  • Phone: (727) 542-9009

Map and Directions

Get Directions

NPI Details

Richard Knipe, MD is a medical oncology internal medicine in St Petersburg, FL. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Richard Knipe, MD NPI is 1336120336. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

375 BRIGHTWATERS BLVD NE
ST PETERSBURG, FL
ZIP 33704-709
Phone: (727) 542-9009

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Magnesium level (HCPCS:83735)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Protein measurement, serum (HCPCS:84165)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Red blood count, automated test (HCPCS:85045)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Automated urinalysis test (HCPCS:81003)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Red blood count, manual test (HCPCS:85044)
  • Folic acid level, serum (HCPCS:82746)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)

The enumeration date for this NPI number is 11/8/2005 and was last updated on 2/5/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyME0061570FLORIDANo
2207RX0202XInternal MedicineMedical OncologyME0061570FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1251022700MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.